BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16335888)

  • 1. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
    Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect.
    Yao EH; Fukuda N; Matsumoto T; Kobayashi N; Katakawa M; Yamamoto C; Tsunemi A; Suzuki R; Ueno T; Matsumoto K
    Hypertens Res; 2007 Nov; 30(11):1119-28. PubMed ID: 18250561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure.
    Kumai Y; Ooboshi H; Ago T; Ishikawa E; Takada J; Kamouchi M; Kitazono T; Ibayashi S; Iida M
    Exp Neurol; 2008 Apr; 210(2):441-8. PubMed ID: 18177860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function.
    Baumann M; Megens R; Bartholome R; Dolff S; van Zandvoort MA; Smits JF; Struijker-Boudier HA; De Mey JG
    Hypertens Res; 2007 Sep; 30(9):853-61. PubMed ID: 18037779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of retinal vasculature by losartan against apoptosis and vasculopathy in rats with spontaneous hypertension.
    Yang D; Zhang M; Huang X; Fang F; Chen B; Wang S; Cai J; Shi X; Qu J; Geng YJ
    J Hypertens; 2010 Mar; 28(3):510-9. PubMed ID: 20051910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
    Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
    Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
    J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
    Xu L; Liu Y
    Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T; Honma H; Ikeda Y; Kuroyanagi R; Takano H; Obata J; Sato T; Kimura H; Yoshida Y; Tamura K
    Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
    Takai S; Jin D; Ikeda H; Sakonjo H; Miyazaki M
    Hypertens Res; 2009 Oct; 32(10):853-60. PubMed ID: 19662023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.